2017
DOI: 10.1111/nep.13180
|View full text |Cite
|
Sign up to set email alerts
|

Adenine‐induced chronic kidney disease in rats

Abstract: Summary at a Glance This invited review article describes the adenine model of chronic kidney disease in rodents and compares its features with other rodent models of kidney disease.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
2

Citation Types

13
149
1
3

Year Published

2018
2018
2023
2023

Publication Types

Select...
9

Relationship

0
9

Authors

Journals

citations
Cited by 200 publications
(166 citation statements)
references
References 56 publications
13
149
1
3
Order By: Relevance
“…The validity of feeding adenine as a rodent model for human CKD has been confirmed before by several authors [10]. Recently a new model of CKD, using spontaneously diabetic Torii rats has been reported, and was found to be particularly useful in CKD with mineral bone disorder [35].…”
Section: Discussionmentioning
confidence: 62%
“…The validity of feeding adenine as a rodent model for human CKD has been confirmed before by several authors [10]. Recently a new model of CKD, using spontaneously diabetic Torii rats has been reported, and was found to be particularly useful in CKD with mineral bone disorder [35].…”
Section: Discussionmentioning
confidence: 62%
“…In conclusion, in this work we show that the limited time slot and overall induced toxicity dramatically limits the feasibility to deploy AAI as a chemical to set-up a renal fibrosis model in zebrafish. However, it can be expected that other renal fibrogenic compounds like adenine or folic acid [5,6] with substantially lower systemic toxicity could offer advantages over AAI, and further experimental work exploring the renal fibrogenic potential of these compounds in tert −/− but possibly also in wild type (WT) zebrafish is warranted.…”
Section: Discussionmentioning
confidence: 99%
“…These include TGFb1-induced in vitro fibrosis models [2] and in vivo CKD models such as the TGFb1 overexpressing mice model [3] and the unilateral ureteral obstruction (UUO) model [4]. In addition, also chemically-induced models based on the chronic treatment of rodents with compounds like adenine [5], folic acid [6], and aristolochic acid [7,8] have been used. Aristolochic acid (AA)-induced nephropathy in humans is characterized by progressive renal interstitial fibrosis leading to ESRD and urothelial malignancy and has been observed after unintentional oral intake of Aristolochia species [9].…”
Section: Introductionmentioning
confidence: 99%
“…As most rodent models for CKD have studied male animals only [11], we focused on this sex, expecting more homogenous and pronounced effects. Frequently used rat CKD models are induced by ureteral obstruction, ischemia/reperfusion injury, or subtotal 5/6 nephrectomy.…”
Section: Discussionmentioning
confidence: 99%